Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6759)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 24, 2021 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Moubarak MM, Chanouha N, Abou Ibrahim N, Khalife H, Gali-Muhtasib H. Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer. World J Clin Oncol 2021; 12(5): 342-354 [PMID: 34131566 DOI: 10.5306/wjco.v12.i5.342] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i5/342.htm |
| Number | Citing Articles |
| 1 |
Sanja Stojanović, Ivana Damnjanović, Jelena Najdanović, Tanja Džopalić, Stevo Najman. In vitro analysis of the biological activity of royal jelly on different cell lines. Hrana i ishrana 2021; 62(2): 1 doi: 10.5937/hraIsh2102001S
|
| 2 |
Wamidh H. Talib, Dima Awajan, Reem Ali Hamed, Aya O. Azzam, Asma Ismail Mahmod, Intisar Hadi AL-Yasari. Combination Anticancer Therapies Using Selected Phytochemicals. Molecules 2022; 27(17): 5452 doi: 10.3390/molecules27175452
|
| 3 |
Sawsan Elgohary, Reda A. Eissa, Hend M. El Tayebi. Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients. International Journal of Molecular Sciences 2023; 24(18): 14254 doi: 10.3390/ijms241814254
|
| 4 |
Maria G. Campos, Ofelia Anjos, Saboor Ahmad. Bee Products and Their Applications in the Food and Pharmaceutical Industries. 2022; : 221 doi: 10.1016/B978-0-323-85400-9.00007-1
|
| 5 |
Amal Hofni, Fares E.M. Ali, Ahmed R. N. Ibrahim, Esam M. Aboubaker. Renoprotective Effect of Thymoquinone against Streptozotocin-Induced
Diabetic Nephropathy: Role of NOX2 and Nrf2 Signals. Current Molecular Pharmacology 2023; 16(8) doi: 10.2174/1874467216666230125150112
|
| 6 |
Eltayeb E. M. Eid, Amer A. Almaiman, Salah Abdalrazak Alshehade, Wardah Alsalemi, Sareh Kamran, FakhrEldin O. Suliman, Mohammed Abdullah Alshawsh. Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications. Molecules 2023; 28(10): 4096 doi: 10.3390/molecules28104096
|
| 7 |
Suzy Salama, Qiyang Shou, Aida A. Abd El-Wahed, Nizar Elias, Jianbo Xiao, Ahmed Swillam, Muhammad Umair, Zhiming Guo, Maria Daglia, Kai Wang, Shaden A. M. Khalifa, Hesham R. El-Seedi. Royal Jelly: Beneficial Properties and Synergistic Effects with Chemotherapeutic Drugs with Particular Emphasis in Anticancer Strategies. Nutrients 2022; 14(19): 4166 doi: 10.3390/nu14194166
|